Chemicals - Chemicals - Others BSE:33211 NSE:PARABDRUGS Bloomberg:PDL@IN Reuters:PARB.BO Market Lot: 1 Face Value: 10 ISIN Demat: INE618H01016
Company Announcements
Fixation Of 'Record Date' For Suspension Of Trading Of Units/Scrip
25-JAN-21
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
22-JAN-21
Corporate Action-Intimation of Delisting
22-JAN-21
Shareholding for the Period Ended December 31, 2020
21-JAN-21
Statement Of Investor Complaints For The Quarter Ended December 2020
21-JAN-21
Closure of Trading Window
30-DEC-20
Board Meeting Intimation for Considering Revised Unaudited Quarterly Financial Results For The Quarter And Half Year Ended On 30Th September, 2020
30-NOV-20
Board Meeting Intimation for Revised Intimation Under Regulation 29 Of SEB (LODR) Regulations, 2015 Regarding Unaudited Quarterly Financial Results For The Quarter And Half Year Ended On 30Th September, 2020.
12-NOV-20
Board Meeting Intimation for Intimation Under Regulation 29 Of SEB (LODR) Regulations, 2015 Regarding Unaudited Quarterly Financial Results For The Quarter And Half Year Ended On 30Th September, 2020 And Notice For Closure Of Trading Window Of The Company.
06-NOV-20
Certificate Under Regulation 40(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended September 30, 2020
28-OCT-20
Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 For The Half Year Ended September 30, 2020
27-OCT-20
Intimation Of Notice Of Board Meeting- Clarification For Financial Results For Quarter Ending 30 June 2020 - PARABDRUGS
22-OCT-20
